The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors

Molecular Oncology

Volumn 8, Issue 2, 2014, Pages 273-284

  Quigley, David A ^a,b,c   Fiorito, Elisa ^d   Nord, Silje ^a,b   Van Loo, Peter ^e,f   Alnæs, Grethe Grenaker ^a,b   Fleischer, Thomas ^a,b   Tost, Jorg ^g,h   Moen Vollan, Hans Kristian ^a,b   Tramm, Trine ⁱ   Overgaard, Jens ⁱ   Bukholm, Ida R ^j,k   Hurtado, Antoni ^a,b,d   Balmain, Allan ^c   Børresen Dale, Anne Lise ^a,b   Kristensen, Vessela ^a,b,j  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g FONDATION JEAN DAUSSET CEPH   (France)

^h DIF   (France)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

Breast cancer; Chromatin; Estrogen; Expression Quantitative Trait Locus; Genetics

Indexed keywords

ESTROGEN; MESSENGER RNA;

ALLELE; ARTICLE; CANCER CELL; CANCER SUSCEPTIBILITY; CELL STRAIN MCF 7; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; METHYLATION; MRPS30 GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; TUMOR GENE;

BREAST CANCER; CHROMATIN; ESTROGEN; EXPRESSION QUANTITATIVE TRAIT LOCUS; GENETICS;

ALLELES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASM PROTEINS; QUANTITATIVE TRAIT LOCI; RECEPTORS, ESTROGEN;

EID: 84894341726     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.11.008     Document Type: Article

References (50)

1. Bhatti P., Doody M.M., Rajaraman P., Alexander B.H., Yeager M., Hutchinson A., et al. Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists. Radiat. Res. 2010, 173:214-224.
2. Brem R.B., Yvert G., Clinton R., Kruglyak L. Genetic dissection of transcriptional regulation in budding yeast. Science 2002, 296:752-755.
3. Churchill G.A., Doerge R.W. Empirical threshold values for quantitative trait mapping. Genetics 1994, 138:963-971.
4. Cowper-Sal lari R., Zhang X., Wright J.B., Bailey S.D., Cole M.D., Eeckhoute J., et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 2012, 44:1191-1198.
5. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352.
6. Dimas A., Deutsch S., Stranger B., Montgomery S., Borel C., Attar-Cohen H., et al. Common regulatory variation Impacts gene expression in a cell type-dependent manner. Science 2012, 325:1246-1250.
7. Dunham I., Kundaje A., Aldred S.F., Collins P.J., Davis C.A., Doyle F., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
8. Emilsson V., Thorleifsson G., Zhang B., Leonardson A.S., Zink F., et al. Genetics of gene expression and its effect on disease. Nature 2008, 452:423-428.
9. Garcia-Closas M., Couch F.J., Lindstrom S., Michailidou K., Schmidt M.K., Brook M.N., et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 2013, 45:392-398. 398e391-392.
10. Gentleman R. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, Springer Science+Business Media, New York.
11. Gilfillan S., Fiorito E., Hurtado A. Functional genomic methods to study estrogen receptor activity. J.Mammary Gland Biol. Neoplasia 2012, 17:147-153.
12. Giresi P.G., Lieb J.D. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods 2009, 48:233-239.
13. Gross D.S., Garrard W.T. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 1988, 57:159-197.
14. Heiser L.M., Sadanandam A., Kuo W.L., Benz S.C., Goldstein T.C., Ng S., et al. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc. Natl. Acad. Sci. USA 2012, 109:2724-2729.
15. Howie B.N., Donnelly P., Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009, 5:e1000529.
16. Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 2007, 39:870-874.
17. Ji-Hyung Shin S.B., McNeney Brad, Graham Jinko LDheatmap: an R function for graphical display of pairwise linkage disequilibria between single nucleotide polymorphisms. J.Stat. Softw. Code Snippets 2006, 16:1-9.
18. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127.
19. Kaser A., Bogengruber E., Hallegger M., Doppler E., Lepperdinger G., Jantsch M., et al. Brix from xenopus laevis and brx1p from yeast define a new family of proteins involved in the biogenesis of large ribosomal subunits. Biol. Chem. 2001, 382:1637-1647.
20. Kim H.C., Lee J.Y., Sung H., Choi J.Y., Park S.K., Lee K.M., et al. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res. 2012, 14:R56.
21. Kim T.H., Abdullaev Z.K., Smith A.D., Ching K.A., Loukinov D.I., Green R.D., et al. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 2007, 128:1231-1245.
22. Lerch-Gaggl A., Haque J., Li J., Ning G., Traktman P., Duncan S.A. Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation. J.Biol. Chem. 2002, 277:45347-45355.
23. Li J., Humphreys K., Heikkinen T., Aittomäki K., Blomqvist C., Pharoah P.D.P., et al. A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res. Treat 2011, 126:717-727.
24. Li Q., Seo J.H., Stranger B., McKenna A., Pe'er I., Laframboise, et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 2013, 152:633-641.
25. Maere S., Heymans K., Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
26. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
27. Michailidou K., Hall P., Gonzalez-Neira A., Ghoussaini M., Dennis J., Milne R.L., et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 2013, 45:353-361.
28. Milne R.L., Goode E.L., Garcia-Closas M., Couch F.J., Severi G., Hein R., et al. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol. Biomarkers Prev. 2011, 20:2222-2231.
29. Morley M., Molony C.M., Weber T.M., Devlin J.L., Ewens K.G., Spielman R.S., et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004, 430:743-747.
30. Myers A.J., Gibbs J.R., Webster J.A., Rohrer K., Zhao A., Marlowe L., et al. A survey of genetic human cortical gene expression. Nat. Genet. 2007, 39:1494-1499.
31. Nica A.C., Parts L., Glass D., Nisbet J., Barrett A., Sekowska M., et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 2011, 7:e1002003.
32. Pan Y.F., Wansa K.D., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., et al. Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements. J.Biol. Chem. 2008, 283:32977-32988.
33. Phillips J.E., Corces V.G. CTCF: master weaver of the genome. Cell 2009, 137:1194-1211.
34. Pickrell J.K., Marioni J.C., Pai A.A., Degner J.F., Engelhardt B.E., Nkadori, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 2010, 464:768-772.
35. Polyak K. Breast cancer: origins and evolution. J.Clin. Invest. 2007, 117:3155-3163.
36. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J.Hum. Genet. 2007, 81:559-575.
37. Quigley D., Balmain A. Systems genetics analysis of cancer susceptibility: from mouse models to humans. Nat. Rev. Genet. 2009, 10:651-657.
38. Quigley D., To M., Pérez-Losada J., Pelorosso F., Mao J., Nagase H., et al. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 2009, 458:505-508.
39. Quigley D.A., To M.D., Kim I.J., Lin K.K., Albertson D.G., Sjolund, et al. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biol. 2011, 12:R5.
40. R Development Core Team R: a Language and Environment for Statistical Computing 2012, Vienna.
41. Ramasamy A., Trabzuni D., Gibbs J.R., Dillman A., Hernandez D.G., Arepalli S., et al. Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studies. Nucleic Acids Res. 2013, 41:e88.
42. Ritchie M.E., Carvalho B.S., Hetrick K.N., Tavare S., Irizarry R.A. R/bioconductor software for Illumina's Infinium whole-genome genotyping BeadChips. Bioinformatics 2009, 25:2621-2623.
43. Ross-Innes C.S., Brown G.D., Carroll J.S. A co-ordinated interaction between CTCF and ER in breast cancer cells. BMC Genom. 2011, 12:593.
44. Ruiz-Narvaez E.A., Rosenberg L., Rotimi C.N., Cupples L.A., Boggs D.A., Adeyemo A., et al. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study. Breast Cancer Res. Treat 2010, 123:525-530.
45. Schadt E.E., Molony C., Chudin E., Hao K., Yang X., Lum P.Y., et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 2008, 6:e107.
46. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98:10869-10874.
47. Splinter E., Heath H., Kooren J., Palstra R.J., Klous P., Grosveld F., et al. CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes Dev. 2006, 20:2349-2354.
48. Stacey S.N., Manolescu A., Sulem P., Thorlacius S., Gudjonsson S.A., Jonsson G.F., et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 2008, 40:703-706.
49. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., et al. Population genomics of human gene expression. Nat. Genet. 2007, 39:1217-1224.
50. Sun L., Liu Y., Fremont M., Schwarz S., Siegmann M., Matthies R., et al. A novel 52 kDa protein induces apoptosis and concurrently activates c-Jun N-terminal kinase 1 (JNK1) in mouse C3H10T1/2 fibroblasts. Gene 1998, 208:157-166.